Context Therapeutics, Inc. (CNTX)
0.4676
-0.03
(-6.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.4676
0.00 (0.00%)
After-Hours: 18:24
Context Therapeutics Debt to Equity Ratio : 0.0064 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0064 |
| March 31, 2026 | 0.0054 |
| December 31, 2025 | 0.0019 |
| September 30, 2025 | 0.0019 |
| June 30, 2025 | 0.002 |
| March 31, 2025 | 0.0021 |
| December 31, 2024 | 0.0023 |
| September 30, 2024 | 0.0029 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0003 |
| March 31, 2023 | 0.0011 |
| December 31, 2022 | 0.0016 |
| September 30, 2022 | 0.0021 |
| June 30, 2022 | 0.0024 |
| March 31, 2022 | 0.0027 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.1001 |
| March 31, 2021 | -0.1112 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Merck & Co., Inc. | 1.286 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 46.13M |
| Total Liabilities (Quarterly) | 7.962M |
| Shareholders Equity (Quarterly) | 38.17M |
| Current Ratio | 5.786 |
| Net Debt Paydown Yield | -0.02% |